Model No.: 1009119-64-5
Brand: Conbottpharm
Packaging: As required
Productivity: Customized
Transportation: Air
Place of Origin: China
Supply Ability: Commercial
Certificate: Documents Support
Backed by a team of professional, we are engaged in offering superior quality Daclatasvir CAS 1009119-64-5. Daclatasvir (trade name Daklinza) is also called BMS-790052, BMS 790052, EBP 883. Daclatasvir CAS NO 1009119-64-5 is a first-in-class, highly-selective oral HCV NS5A inhibitor that is a useful drug to treat hepatitis C (HCV). We can offer the goods in proper packaging of diverse quantity to meet the requirements of the customers.
Thera. Category: Anti-VIRAL
Cas No.: 1009119-64-5
Synonym: dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate;diMethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl);Daclatasvir;EBP 883;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester;Daclatasvir/EBP883;daclatavir;BMS-790052(Daclatasvir)
Molecular Formula: C40H50N8O6
Molecular Weight: 738.88
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: Daclatasvir (BMS-790052) is a highly selective HCV NS5A inhibitor, EC50 of 9-50 pM, in cell culture, to act on a variety of genotypes of HCV replication and JFH-1 genotype 2a infectious virus.
Related Products:
Product Categories : Intermediates > Anti-Viral Intermediate